<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03218553</url>
  </required_header>
  <id_info>
    <org_study_id>RC17_0029</org_study_id>
    <nct_id>NCT03218553</nct_id>
  </id_info>
  <brief_title>Effects of Perioperative Administration of Dexamethasone on Postoperative Complications and Mortality After Non-cardiac Major Surgery</brief_title>
  <acronym>PACMAN</acronym>
  <official_title>Effects of Perioperative Administration of Dexamethasone on Postoperative Complications and Mortality After Non-cardiac Major Surgery : a Randomized, Multicentre, Double Blind, Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative complications are major healthcare problems and are associated with a reduced
      short-term and long-term survival after surgery. Major surgery is associated with a
      predictable and usually transient Systemic Inflammatory Response (SIRS), depending on the
      magnitude of the surgical trauma. An excessive SIRS syndrome participates to the development
      of postoperative organ dysfunction, infection and mortality. Corticosteroids may decrease the
      postsurgical SIRS in cardiac surgery: in a large multicenter randomized trial, a single
      intravenous administration of high-dose dexamethasone did not reduce the incidence of a
      composite endpoint of adverse events but was associated with a reduced incidence of
      postoperative pulmonary complications and infections and with a reduction in hospital stay.
      However, a similar study, recently published in the Lancet was negative. Evidences from one
      meta-analysis, including 11 studies of moderate quality (439 patients in total), suggest that
      intraoperative administration of corticosteroids during major abdominal surgery decreases
      postoperative complications, including infectious complications, without significant risk of
      anastomotic leakage. At present, no large randomized controlled trial has been performed in
      patients undergoing major non-cardiac surgery. In acute medicine, several lines of evidence
      have shown that low to moderate doses of corticosteroids decrease the excessive inflammatory
      response, without inducing immuno suppression. However, despite the widespread use of
      corticosteroids to reduce postoperative nausea and vomiting and to improve analgesia,
      concerns continue to be raised about their safety, especially regarding an increased risk of
      postoperative infection.

      We hypothesize that the perioperative administration of glucocorticoids would reduce
      postoperative morbidity after major non-cardiac surgery through dampening of the inflammatory
      response. Given the number of surgical patients for whom the question applies, the study is
      of significant clinical importance
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background :

      Postoperative complications are major healthcare problems and are associated with a reduced
      short-term and long-term survival after surgery. Corticosteroids may decrease the
      postsurgical SIRS in cardiac surgery, but this treatment is not recommended yet. The aim of
      the current study is to assess the efficiency and the safety of dexamethasone to prevent on
      postoperative complications.

      Methods :

      The PACMAN trial is a multicenter, randomized, controlled, double-blind, two-arms study. 1222
      patients undergoing major surgery (duration &gt;90 minutes and one or more risk factor of
      postoperative complication) are randomized to dexamethasone (0.2mg/kg at the end of the
      surgery and at day1) or to placebo. The primary outcome is a composite outcome of major
      postoperative complication during 14 days after the surgery.

      Analyzes will be conducted, first, on data from the intention-to-treat (ITT) population,
      second, in the modified intention-to-treat (mITT) population as well as in the per-protocol
      population. All statistical analyzes will take into account stratified randomization (cancer
      and type of surgery) and will be adjusted on the center as random effect as.

      Discussion :

      The PACMAN trial is the first randomized controlled trial powered to investigate whether
      perioperative administration of dexamethasone in high risk patients improve outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 13, 2017</start_date>
  <completion_date type="Actual">April 16, 2019</completion_date>
  <primary_completion_date type="Actual">April 16, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite outcome at least one item among the following:-Postoperative sepsis, severe sepsis, septic shock-Postoperative pulmonary complication: pneumonia, need for invasive and/or noninvasive ventilation for respiratory failure-All-cause mortality</measure>
    <time_frame>14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital free days</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with post operative sepsis</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative intubation rate for respiratory failure</measure>
    <time_frame>28 days</time_frame>
    <description>Postoperative respiratory failure requiring invasive ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with postoperative respiratory failure requiring non-invasive ventilation</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>28 days</time_frame>
    <description>The Clavien-Dindo classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of unplanned hospitalization in intensive care unit</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients developing postoperative organ failures</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood level of marker of inflammation (C Reactive protein)</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delayed healing defined as non hermetic scar</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with Gastric ulcer</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with Digestive bleeding</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with Anastomotic leakage</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dose of insulin</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with Hypokaliemia (&lt; 4 mmol/l)</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with Dysnatremia (&lt;139 mmol/l or &gt; 145 mmol/l)</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with Hypocalcemia (&lt;2.2 mmol/l)</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients with Cardiac events (Atrial fibrillation / cardiac flutter, Acute coronary syndrome or Cardiac failure)</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1222</enrollment>
  <condition>Major Non-cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard cares plus postoperative administrations of glucocorticoid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard cares plus postoperative administrations of placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Dexamethasone : first dose : 0,2mg.kg-1 at the end of the surgical procedure, second dose (0,2 mg.kg-1) 24 hours after the surgery</description>
    <arm_group_label>Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>placebo : first infusion at the end of the surgical procedure, second 24 hours after the surgery</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Major surgery (&gt; 90 minutes and realized under general anesthesia) of the abdomen, pelvis,
        thorax, face/neck, vascular surgery in a patient older than 65 years Or Major surgery (&gt; 90
        minutes and realized under general anesthesia) of the abdomen, pelvis, thorax, face/neck,
        vascular surgery in a patient older than 50 years and presenting one of the following
        criteria

          -  Presence of a defined risk factor for cardiac or respiratory disease (exercise
             tolerance equivalent to 6 metabolic equivalents or less)

          -  Medical history of stroke

          -  Moderate to severe renal impairment (clearance of creatinine ≤ 30 mll/L)

          -  Active smoking

          -  Averaged observed blood losses over 500 ml

          -  Emergency surgery

        Exclusion Criteria:

          -  Pregnant women, Minors, Adults under guardianship or trusteeship

          -  Treatment with systemic corticosteroids at a dose &gt; 5 mg.day-1 of equivalent
             prednisolone in the previous 3 months

          -  Patients with chronic renal failure (clearance of creatinine &lt; 10 ml/min)

          -  Patients for which death is deemed imminent and inevitable or patients with an
             underlying disease process with a life expectancy of less than 1 month

          -  Patient with preoperative shock (defined by the need for vasoactive drugs before
             surgery)

          -  Acute Pulmonary edema in the last 7 days

          -  Active bacterial or viral infection

          -  Allergy to the intravenous formulation of dexamethasone

          -  Uncontrolled psychotic disorder (acute or chronical)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU La Cavale Blanche</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Estaing, CHU de Clermont Ferrand</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Beaujon</name>
      <address>
        <city>Clichy</city>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHD Vendée</name>
      <address>
        <city>La Roche-sur-Yon</city>
        <zip>85000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Du Mans</name>
      <address>
        <city>Le Mans</city>
        <zip>72037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Claude Huriez</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Timone</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13975</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint-Eloi</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Jules Verne</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Le Confluent</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hotel Dieu Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Laennec</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>C.R.L.C.C. Nantes Atlantique</name>
      <address>
        <city>Nantes</city>
        <zip>44805</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires Saint-Louis, Lariboisière, Fernand Widal</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Lyon Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <zip>69310</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ch Quimper</name>
      <address>
        <city>Quimper</city>
        <zip>29107</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Saint Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nouvel Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Valenciennes</name>
      <address>
        <city>Valenciennes</city>
        <zip>59300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>July 10, 2017</study_first_submitted>
  <study_first_submitted_qc>July 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2017</study_first_posted>
  <last_update_submitted>May 28, 2020</last_update_submitted>
  <last_update_submitted_qc>May 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

